IGF-1 LR3 dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (20 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 12–17 mcg | 0.01–0.02 mL | 1–1 units0.00–0.01 mL | 5.0 d |
| 60–75 kg / 132–165 lb | 15–21 mcg | 0.01–0.02 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| 75–90 kg / 165–198 lb | 19–25 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| 90–105 kg / 198–231 lb | 22–30 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| >105 kg / >231 lb | 26–35 mcg | 0.03–0.04 mL | 1–1 units0.01–0.01 mL | 5.0 d |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. Five half-lives is the conventional washout window where ~3% of peak plasma remains, a useful "next dose due" anchor for IGF-1 LR3 (t½ 1.0 d).
IGF-1 LR3 by goal
Read IGF-1 LR3's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the IGF-1 LR3 bibliography for relevance to dosing and pharmacokinetics.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.